Project: Evolution in time of predictive biological markers in breastcancer, influence of cytostatic and hormonal neoadjuvant and/or adjuvant and/or palliative treatment.
- project duration
- 31-DEC-99 – 31-DEC-99
- The evolution of predictive markers (hormone receptor content, cERB2, cERB3, epidermal growth factor receptor, Cathepsine D) in breast cancer patients under different types of treatment will be evaluated. The aim of this study is to ameliorate the prediction of prognosis of these patients by considering this evolution in time in stead of a point of evaluation. Furthermore a new technique of determination of the hormone receptor content will be developed.